Hanson McClain Advisors »

Parabilis Medicines shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7k 100 27.37

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Series Trust ST STR P500GRW (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Spdr Series Trust St Str P500val (SPYV)
Apple Call Call Option (Principal) (AAPL)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds St Port Mark Etf (SPEM)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Mbs Etf (MBB)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)

View all positions for Hanson McClain Advisors

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Alphabet
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Siren
Farallon Capital Management
Jupiter Topco
Frazier Life Sciences Management
Deerfield Management Company
General Catalyst Group Management
General Atlantic

View all funds holding Parabilis Medicines